Physical Disability in Patients Treated With Betaferon

Bayer83 enrolled

Overview

To gather Observation data about physical disability progression, safety and adherence during the use of Betaferon in daily practice. Patients with any type of Multiple Sclerosis (MS) (MRRS) (PSMS), under treatment with Betaferon.Open Multicentric Observational study.24 months.Evaluation of physical disability in patients treated with Betaferon, using Kurtzke's expanded disability scale (EDSS) in biannual periods

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Sclerosis

Interventions

Interferon-1beta (Betaseron, BAY86-5046)DRUG

Patients with a first demyelinating event suggestive of MS, as well as patients with remittent recurrent MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS) will be observed.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a first demyelinating event suggestive of MS, as well as patients with remittent recurrent MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS) will be able to join the study. Exclusion Criteria: * Pregnancy * Patients with a history of hypersensitivity to natural or recombinant interferon-beta, human albumin or to any of the excipients * Patients with a history of severe depressive disorders and/or suicidal ideation * Patient with decompensated liver disease * Patient with epilepsy not adequately controlled by treatment

Locations (1)

Unnamed facility

Many Locations, Colombia

Outcomes

Primary Outcomes

To collect observational local data about effectivity related to physical disability progression on the daily routine basis in patients treated with Betaferon

Time frame: Every 6 months for 2 years

Secondary Outcomes

To evaluate Betaferon safety on the daily routine basis

Time frame: Every 6 months

To evaluate patient adherence to Betaferon treatment

Time frame: Every 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.